Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroendocrine Tumors 12Neoplasms 8Carcinoid Tumor 7Diarrhea 6Colorectal Neoplasms 6Carcinoma, Hepatocellular 6Breast Neoplasms 5Acromegaly 5Vipoma 4Stomach Neoplasms 4Somatostatinoma 4Rectal Neoplasms 4Insulinoma 4Glucagonoma 4Gastro-enteropancreatic neuroendocrine tumor 4Esophageal Neoplasms 4Carcinoma, Islet Cell 4Adenoma, Islet Cell 4Weight Loss 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Intestinal Obstruction 3Gastrinoma 3Colonic Neoplasms 3Carcinoma 3Thymoma 2Pituitary Neoplasms 2Ovarian Neoplasms 2Meningioma 2

Interventions

Pancreaticoduodenectomy 2Sulfasalazine 1Serum Albumin, Human 1Saline Solution 1Pyloromyotomy 1Pancreatectomy 1Octreotide 1Endoscopy 1Botulinum Toxins, Type A 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastroparesis × Octreotide × Clear all
NCT03734627 2021-08-16

EndoGut

St. James's Hospital, Ireland

Completed
40 enrolled
Gastrointestinal

Feeding and Eating Disorders, Dumping Syndrome, Esophageal Neoplasms, Insulin Resistance, Nutrition Disorders, Gastroparesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡